RETRACTED: Overexpression of SphK1 enhances cell proliferation and invasion in triple-negative breast cancer via the PI3K/AKT signaling pathway (Retracted article. See April, 2017)

被引：30
|
作者：
Li, Jun [1 ]
Song, Zhangjun [2 ]
Wang, Yiyu [1 ]
Yin, Yue [1 ]
Liu, Ying [1 ]
Yuan, Rong [1 ]
Nan, Xing [1 ]
机构：
[1] Shaanxi Prov Tumor Hosp, Tumor Res Ctr, 309 YanTa West Rd, Xian 710061, Peoples R China
[2] Shaanxi Prov Tumor Hosp, Breast Surg Ctr, Xian 710061, Peoples R China
来源：
TUMOR BIOLOGY | 2016年 / 37卷 / 08期
关键词：
Sphingosine kinase 1; Sphingosine-1-phosphate; Triple-negative breast cancer; Chemotherapy; AKT; PI3K; SPHINGOSINE KINASE 1; THERAPEUTIC TARGET; COLON-CANCER; SURVIVAL; 1-PHOSPHATE; EXPRESSION; PROGNOSIS; APOPTOSIS;
D O I：
10.1007/s13277-016-4954-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Sphingosine kinase 1 (SphK1) expression is elevated in various cancers and is associated with shorter survival times for patients. However, the molecular mechanism of SphK1 up-regulation in triple-negative breast cancer (TNBC) remains unclear. In this study, we assayed the expression level of SphK1 in TNBC tissues by qRT-PCR and immunohistochemistry. The level of S1P was quantified by ELISA in the serum of TNBC patients. Our results found that the levels of SphK1 and S1P were significantly increased in TNBC patients compared with normal control. Furthermore, knockdown of SphK1 with siRNA decreased TNBC cell proliferation and inhibited cell migration/invasion. These data suggest that SphK1 has an important role in TNBC and presents an attractive therapeutic target for the treatment for TNBC.
引用
收藏
页码：10587 / 10593
页数：7
相关论文
共 50 条
  • [1] RETRACTED: SPHK1 inhibitor suppresses cell proliferation and invasion associated with the inhibition of NF-κB pathway in hepatocellular carcinoma (Retracted article. See April, 2017)
    Zhang, Zijie
    Yan, Zhenyu
    Yuan, Zheng
    Sun, Yanzhen
    He, Haifa
    Mai, Chunyang
    TUMOR BIOLOGY, 2015, 36 (03) : 1503 - 1509
  • [2] RETRACTED: Silencing of EPCAM suppresses hepatic fibrosis and hepatic stellate cell proliferation in mice with alcoholic hepatitis via the PI3K/Akt/mTOR signaling pathway (Retracted article. See JAN, 2023)
    Zhang, Zhi
    Wen, Huiqing
    Weng, Jun
    Feng, Lei
    Liu, Hongya
    Hu, Xiaojun
    Zeng, Fanhong
    CELL CYCLE, 2019, 18 (18) : 2239 - 2254
  • [3] RETRACTED: Oxymatrine Inhibits the Proliferation and Invasion of Breast Cancer Cells via the PI3K Pathway (Retracted article. See vol. 14, pg. 2289, 2022)
    Guo, Lin
    Yang, Tengfei
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 10499 - 10508
  • [4] RETRACTED: Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway (Retracted Article)
    Wang, Li-Li
    Huang, Wei-Wei
    Huang, Jing
    Huang, Rong-Fang
    Li, Na-Ni
    Hong, Yi
    Chen, Mu-Lan
    Wu, Fan
    Liu, Jian
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2020, 36 (08) : 581 - 591
  • [5] Sericin inhibits MDA-MB-468 cell proliferation via the PI3K/Akt pathway in triple-negative breast cancer
    Niu, Lin
    Yang, Songhe
    Zhao, Xueying
    Liu, Xiaochao
    Si, Lina
    Wei, Meng
    Liu, Lei
    Cheng, Luyang
    Qiao, Yuebing
    Chen, Zhihong
    MOLECULAR MEDICINE REPORTS, 2021, 23 (02)
  • [6] RETRACTED: Sapylin inhibits lung cancer cell proliferation and promotes apoptosis by attenuating PI3K/AKT signaling (Retracted Article)
    Zhang, Lin
    Liu, Benhong
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (09) : 14679 - 14687
  • [7] Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway
    Wu, Tianqi
    Song, Hongming
    Xie, Dan
    Zhao, Bingkun
    Xu, Hui
    Wu, Chenyang
    Hua, Kaiyao
    Deng, Yijun
    Ji, Changle
    Hu, Jiashu
    Fang, Lin
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (06) : 2001 - 2010
  • [8] RETRACTED: Cucurbitacin E inhibits osteosarcoma cells proliferation and invasion through attenuation of PI3K/AKT/mTOR signalling pathway (Retracted Article)
    Wang, Ying
    Xu, Shumei
    Wu, Yaochi
    Zhang, Junfeng
    BIOSCIENCE REPORTS, 2016, 36
  • [9] RETRACTED: Fangchinoline targets PI3K and suppresses PI3K/AKT signaling pathway in SGC7901 cells (Retracted article. See vol. 63, 2023)
    Tian, Feng
    Ding, Ding
    Li, Dandan
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 46 (06) : 2355 - 2363
  • [10] RETRACTED: MiR-101 reduces cell proliferation and invasion and enhances apoptosis in endometrial cancer via regulating PI3K/Akt/mTOR (Retracted article. See vol. 30, pg. 275, 2021)
    Zhang, Suxia
    Wang, Min
    Li, Qirong
    Zhu, Ping
    CANCER BIOMARKERS, 2018, 21 (01) : 179 - 186
12345